NR1H4 and metabolic dysfunction-associated steatotic liver disease: Taken together, our results indicate an enterohepatic impairment of FXR signaling in NAFLD pigs, with dysregulation of FXR downstream metabolic and inflammatory pathways in the liver and reduced FXR-induced FGF19 synthesis in the DI.